NDC product
Cisatracurium Besylate
NDC 0703-2056 · Teva Parenteral Medicines, Inc.
Key facts
| Product NDC | 0703-2056 |
|---|---|
| Proprietary name | Cisatracurium Besylate |
| Labeler | Teva Parenteral Medicines, Inc. |
| Marketing category | ANDA |
| Application number | ANDA209334 |
| Marketing start | Sep 4, 2018 |
| Marketing end | Apr 30, 2025 |
| Listing certified through | Apr 30, 2025 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: